Maturation of Insulin Response to Glucose During Human Fetal and Neonatal Development: Studies with Perifusion of Pancreatic Isletlike Cell Clusters

Author:

Otonkoski Timo1,Andersson Sture1,Knip Mikael1,Simell Olli1

Affiliation:

1. Children's Hospital, University of Helsinki Helsinki Department of Pediatrics, University of Oulu Oulu Department of Pediatrics, University of Turku Turku, Finland

Abstract

The insulin release in response to glucose was studied in perifused isletlike cell clusters (ICCs) obtained from human fetal or neonatal pancreases at various stages of development: 12–15 gestational wk (n = 7), 17–20 wk (n = 13), 22.5 wk (n = 2, 1 diabetic pregnancy), and 26–44 wk (n = 6, postnatal samples). The ICCs were stimulated with 20 mM glucose and subsequently with 10 mM theophylline plus 20 mM glucose as a viability test. Insulin release increased to a detectable level (> 0.1 pg · ICC−1 · min−1) during glucose stimulation in four of seven of the youngest fetuses. At 17–20 wk the basal rate of insulin release had increased by at least 15-fold above the detection limit (1.5 pg · ICC−1 · min−1), and glucose promoted a sustained monophasic response that was on the average 1.6-fold higher than the basal level. The response was significant (P < .05) in 9 of 13 experiments. With postnatal ICC (gestational age 26–44 wk), an early-phase peak response was observed in 5 of 6 experiments. The mean rates of insulin release after 5–12 min of glucose stimulation were 4.8 pg.ICC−1 · min−1 in newborn infants and 2.1 pg.ICC−1 · min−1 in 17- to 20-wk fetuses. The corresponding mean relative insulin responses (stimulated to basal) were 3.3-fold (range 1.1–7.5) and 1.6-fold (1.0–3.4), respectively (P < .05, Mann-Whitney U test). The results suggest that the human fetal pancreas is already responsive to glucose during the first half of gestation, but the biphasic insulin release does not start to mature until the postnatal phase.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3